Found: 30
Select item for more details and to access through your institution.
Binding Folate Receptor Alpha Autoantibody Is a Biomarker for Leucovorin Treatment Response in Autism Spectrum Disorder.
- Published in:
- Journal of Personalized Medicine, 2024, v. 14, n. 1, p. 62, doi. 10.3390/jpm14010062
- By:
- Publication type:
- Article
Age-Related Changes in Epilepsy Characteristics and Response to Antiepileptic Treatment in Autism Spectrum Disorders.
- Published in:
- Journal of Personalized Medicine, 2023, v. 13, n. 7, p. 1167, doi. 10.3390/jpm13071167
- By:
- Publication type:
- Article
The Rationale for Vitamin, Mineral, and Cofactor Treatment in the Precision Medical Care of Autism Spectrum Disorder.
- Published in:
- Journal of Personalized Medicine, 2023, v. 13, n. 2, p. 252, doi. 10.3390/jpm13020252
- By:
- Publication type:
- Article
The Soluble Folate Receptor in Autism Spectrum Disorder: Relation to Autism Severity and Leucovorin Treatment.
- Published in:
- Journal of Personalized Medicine, 2022, v. 12, n. 12, p. 2033, doi. 10.3390/jpm12122033
- By:
- Publication type:
- Article
Long COVID Syndrome Presenting as Neuropsychiatric Exacerbations in Autism Spectrum Disorder: Insights for Treatment.
- Published in:
- Journal of Personalized Medicine, 2022, v. 12, n. 11, p. 1815, doi. 10.3390/jpm12111815
- By:
- Publication type:
- Article
Correction: Rossignol, D.A.; Frye, R.E. Cerebral Folate Deficiency, Folate Receptor Alpha Autoantibodies and Leucovorin (Folinic Acid) Treatment in Autism Spectrum Disorders: A Systematic Review and Meta-Analysis. J. Pers. Med. 2021, 11 , 1141.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
A Personalized Approach to Evaluating and Treating Autism Spectrum Disorder.
- Published in:
- Journal of Personalized Medicine, 2022, v. 12, n. 2, p. N.PAG, doi. 10.3390/jpm12020147
- By:
- Publication type:
- Article
Cerebral Folate Deficiency, Folate Receptor Alpha Autoantibodies and Leucovorin (Folinic Acid) Treatment in Autism Spectrum Disorders: A Systematic Review and Meta-Analysis.
- Published in:
- Journal of Personalized Medicine, 2021, v. 11, n. 11, p. 1141, doi. 10.3390/jpm11111141
- By:
- Publication type:
- Article
Ratings of the Effectiveness of Nutraceuticals for Autism Spectrum Disorders: Results of a National Survey.
- Published in:
- Journal of Personalized Medicine, 2021, v. 11, n. 9, p. 878, doi. 10.3390/jpm11090878
- By:
- Publication type:
- Article
The Effectiveness of Cobalamin (B12) Treatment for Autism Spectrum Disorder: A Systematic Review and Meta-Analysis.
- Published in:
- Journal of Personalized Medicine, 2021, v. 11, n. 8, p. 784, doi. 10.3390/jpm11080784
- By:
- Publication type:
- Article
A Systematic Review and Meta-Analysis of Immunoglobulin G Abnormalities and the Therapeutic Use of Intravenous Immunoglobulins (IVIG) in Autism Spectrum Disorder.
- Published in:
- Journal of Personalized Medicine, 2021, v. 11, n. 6, p. 488, doi. 10.3390/jpm11060488
- By:
- Publication type:
- Article
E5531, a synthetic non-toxic lipid A derivative blocks the immunobiological activities of lipopolysaccharide.
- Published in:
- British Journal of Pharmacology, 1999, v. 127, n. 4, p. 853, doi. 10.1038/sj.bjp.0702596
- By:
- Publication type:
- Article
Blocking of Responses to Endotoxin by E5564 in Healthy Volunteers with Experimental Endotoxemia.
- Published in:
- Journal of Infectious Diseases, 2003, v. 187, n. 4, p. 631, doi. 10.1086/367990
- By:
- Publication type:
- Article
Elevated Plasma Levels of Limulus Amoebocyte Lysate--Reactive Material.
- Published in:
- 2006
- By:
- Publication type:
- Letter
Frye and Rossignol reply.
- Published in:
- Developmental Medicine & Child Neurology, 2011, v. 53, n. 11, p. 1064, doi. 10.1111/j.1469-8749.2011.04088.x
- By:
- Publication type:
- Article
Melatonin in autism spectrum disorders: a systematic review and meta-analysis.
- Published in:
- Developmental Medicine & Child Neurology, 2011, v. 53, n. 9, p. 783, doi. 10.1111/j.1469-8749.2011.03980.x
- By:
- Publication type:
- Article
Substantial Problems with Measuring Brain Mitochondrial Dysfunction in Autism Spectrum Disorder Using Magnetic Resonance Spectroscopy.
- Published in:
- Journal of Autism & Developmental Disorders, 2012, v. 42, n. 4, p. 640, doi. 10.1007/s10803-011-1276-z
- By:
- Publication type:
- Article
Accelerated Transplant Coronary Artery Disease and Massive Silent Acute Myocardial Infarction in a Heart Transplant Patient.
- Published in:
- Angiology, 1999, v. 50, n. 11, p. 947, doi. 10.1177/000331979905001110
- By:
- Publication type:
- Article
Evidence linking oxidative stress, mitochondrial dysfunction, and inflammation in the brain of individuals with autism.
- Published in:
- Frontiers in Physiology, 2014, v. 5, p. 1, doi. 10.3389/fphys.2014.00150
- By:
- Publication type:
- Article
Clinical and Molecular Characteristics of Mitochondrial Dysfunction in Autism Spectrum Disorder.
- Published in:
- Molecular Diagnosis & Therapy, 2018, v. 22, n. 5, p. 571, doi. 10.1007/s40291-018-0352-x
- By:
- Publication type:
- Article
Hyperbaric treatment for children with autism: a multicenter, randomized, double-blind, controlled trial.
- Published in:
- BMC Pediatrics, 2009, v. 9, p. 1, doi. 10.1186/1471-2431-9-21
- By:
- Publication type:
- Article
The effects of hyperbaric oxygen theraphy on oxidative stress, inflammation, and symptoms in children with autism: an open-label pilot study.
- Published in:
- BMC Pediatrics, 2007, v. 7, p. 36, doi. 10.1186/1471-2431-7-36
- By:
- Publication type:
- Article
Safety, Pharmacokinetics, and Pharmacodynamics of E5564, a Lipid a Antagonist, during an Ascending Single-Dose Clinical Study.
- Published in:
- Journal of Clinical Pharmacology, 2003, v. 43, n. 7, p. 735, doi. 10.1177/0091270003043007007
- By:
- Publication type:
- Article
The TLR4 antagonist Eritoran protects mice from lethal influenza infection.
- Published in:
- Nature, 2013, v. 497, n. 7450, p. 498, doi. 10.1038/nature12118
- By:
- Publication type:
- Article
Identification and Treatment of Pathophysiological Comorbidities of Autism Spectrum Disorder to Achieve Optimal Outcomes.
- Published in:
- Clinical Medicine Insights: Pediatrics, 2016, n. 10, p. 43, doi. 10.4137/CMPed.s38337
- By:
- Publication type:
- Article
Biomarker-Guided Interventions of Clinically Relevant Conditions Associated with Autism Spectrum Disorders and Attention Deficit Hyperactivity Disorder.
- Published in:
- Alternative Medicine Review, 2010, v. 15, n. 1, p. 15
- By:
- Publication type:
- Article
Influence of Plasma Cholesterol and Triglyceride Concentrations and Eritoran (E5564) Micelle Size on its Plasma Pharmacokinetics and Ex Vivo Activity Following Single Intravenous Bolus Dose Into Healthy Female Rabbits.
- Published in:
- Pharmaceutical Research, 2008, v. 25, n. 1, p. 176, doi. 10.1007/s11095-007-9428-8
- By:
- Publication type:
- Article
Safety, pharmacokinetics and pharmacodynamics of four-hour intravenous infusions of eritoran in healthy Japanese and Caucasian men.
- Published in:
- Innate Immunity, 2012, v. 18, n. 6, p. 793, doi. 10.1177/1753425912441845
- By:
- Publication type:
- Article
Continuous pharmacodynamic activity of eritoran tetrasodium, a TLR4 antagonist, during intermittent intravenous infusion into normal volunteers.
- Published in:
- Innate Immunity, 2008, v. 14, n. 6, p. 383, doi. 10.1177/1753425908099173
- By:
- Publication type:
- Article
Antagonism of in vivo and ex vivo response to endotoxin by E5564, a synthetic lipid A analogue.
- Published in:
- Innate Immunity, 2002, v. 8, n. 6, p. 483, doi. 10.1177/09680519020080060601
- By:
- Publication type:
- Article